Other revenues — Total Revenues
Bristol-Myers Squibb Other revenues — Total Revenues decreased by 18.1% to $227M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $227M to $227M. Over 4 years (FY 2021 to FY 2025), Other revenues — Total Revenues shows an upward trend with a 12.7% CAGR.
Analysis
How to read this metric
An increase may indicate successful monetization of intellectual property or growth in ancillary services, while a decrease suggests a narrowing focus on core therapeutic areas or the expiration of non-core revenue streams.
Detailed definition
This metric represents the portion of total consolidated revenue derived from secondary business activities, ancillary s...
Peer comparison
Most large-cap pharmaceutical peers report similar 'other' or 'miscellaneous' revenue categories, typically representing a small single-digit percentage of total sales, often driven by royalties or licensing agreements.
bmy_segment_other_revenues_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $153.5M | $153.5M | $153.5M | $152M | $203M | $232M | $159M | $145M | $130M | $183M | $162M | $172M | $160M | $304M | $407M | $227M | $241M | $247M | $277M | $227M |
| QoQ Change | — | +0.0% | +0.0% | -1.0% | +33.6% | +14.3% | -31.5% | -8.8% | -10.3% | +40.8% | -11.5% | +6.2% | -7.0% | +90.0% | +33.9% | -44.2% | +6.2% | +2.5% | +12.1% | -18.1% |
| YoY Change | — | — | — | — | +32.2% | +51.1% | +3.6% | -4.6% | -36.0% | -21.1% | +1.9% | +18.6% | +23.1% | +66.1% | +151.2% | +32.0% | +50.6% | -18.8% | -31.9% | +0.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's other revenues — total revenues?
- Bristol-Myers Squibb (BMY) reported other revenues — total revenues of $227M in Q1 2026.
- How has Bristol-Myers Squibb's other revenues — total revenues changed year-over-year?
- Bristol-Myers Squibb's other revenues — total revenues decreased by 0.0% year-over-year, from $227M to $227M.
- What is the long-term trend for Bristol-Myers Squibb's other revenues — total revenues?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's other revenues — total revenues has grown at a 12.7% compound annual growth rate (CAGR), from $614M to $992M.
- What does other revenues — total revenues mean?
- The percentage of total revenue generated from secondary business activities outside of the company's core pharmaceutical product segments.